Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 14 01:46PM ET
14.38
Dollar change
-0.67
Percentage change
-4.45
%
IndexRUT P/E- EPS (ttm)-3.18 Insider Own5.03% Shs Outstand139.51M Perf Week-20.86%
Market Cap2.02B Forward P/E- EPS next Y-0.64 Insider Trans-0.67% Shs Float133.34M Perf Month11.47%
Income-398.71M PEG- EPS next Q1.00 Inst Own56.88% Short Float28.66% Perf Quarter171.83%
Sales996.61M P/S2.03 EPS this Y107.92% Inst Trans3.20% Short Ratio2.63 Perf Half Y168.28%
Book/sh-6.18 P/B- EPS next Y-248.48% ROA-27.53% Short Interest38.21M Perf Year86.27%
Cash/sh3.50 P/C4.11 EPS next 5Y37.90% ROE- 52W Range3.53 - 23.86 Perf YTD199.58%
Dividend Est.- P/FCF- EPS past 5Y11.55% ROI- 52W High-39.73% Beta2.00
Dividend TTM- Quick Ratio0.88 Sales past 5Y513.29% Gross Margin64.69% 52W Low307.09% ATR (14)1.86
Dividend Ex-DateDec 13, 2007 Current Ratio0.90 EPS Y/Y TTM78.36% Oper. Margin-37.92% RSI (14)50.64 Volatility10.86% 13.68%
Employees1543 Debt/Eq- Sales Y/Y TTM-26.66% Profit Margin-40.01% Recom2.00 Target Price22.80
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q69.08% Payout- Rel Volume1.22 Prev Close15.05
Sales Surprise-7.22% EPS Surprise1.32% Sales Q/Q15.94% EarningsMay 10 BMO Avg Volume14.53M Price14.38
SMA20-10.87% SMA5048.81% SMA200113.66% Trades Volume11,968,849 Change-4.45%
Date Action Analyst Rating Change Price Target Change
May-10-24Upgrade JP Morgan Underweight → Neutral
May-10-24Upgrade BofA Securities Underperform → Neutral $4 → $12
Aug-09-23Upgrade B. Riley Securities Neutral → Buy $15
Apr-20-23Downgrade TD Cowen Outperform → Market Perform $55 → $10
Mar-01-23Downgrade B. Riley Securities Buy → Neutral $29 → $10
Jan-09-23Reiterated B. Riley Securities Buy $74 → $37
Dec-30-22Reiterated H.C. Wainwright Buy $207 → $110
Dec-02-22Initiated Jefferies Hold
Sep-22-22Downgrade JP Morgan Neutral → Underweight $132 → $27
May-20-22Initiated BofA Securities Underperform $35
Today 04:55AM
Jun-13-24 03:53PM
Jun-11-24 06:00AM
05:10AM
Jun-10-24 09:00AM
07:30AM Loading…
Jun-07-24 07:30AM
Jun-06-24 04:37PM
04:15PM
11:38AM
10:48AM
09:58AM
09:28AM
Jun-05-24 04:51PM
Jun-04-24 06:00AM
Jun-03-24 05:43PM
03:41PM Loading…
03:41PM
01:23PM
Jun-01-24 06:01AM
May-31-24 06:57AM
May-30-24 09:25AM
May-28-24 09:00AM
May-24-24 05:55PM
08:15AM
May-23-24 12:45PM
06:45AM
May-22-24 10:48AM
09:45AM
05:50AM
May-21-24 09:01AM
06:27AM
03:29PM Loading…
May-20-24 03:29PM
02:31PM
01:53PM
01:37PM
07:40AM
07:39AM
06:35AM
May-19-24 08:49AM
May-18-24 07:35AM
May-17-24 06:45AM
05:40AM
May-16-24 09:15AM
06:34AM
May-15-24 02:31PM
08:00AM
06:48AM
06:32AM
05:35AM
May-14-24 11:01AM
10:24AM
06:47AM
05:11AM
May-13-24 04:02PM
12:51PM
10:24AM
03:03AM
May-10-24 06:56PM
05:56PM
04:26PM
04:16PM
04:11PM
04:08PM
02:54PM
01:58PM
01:46PM
01:44PM
01:27PM
01:24PM
01:24PM
01:08PM
01:07PM
01:02PM
12:49PM
12:41PM
12:28PM
12:06PM
11:43AM
11:31AM
11:25AM
10:53AM
10:36AM
10:34AM
10:20AM
10:14AM
10:06AM
10:06AM
10:05AM
09:54AM
09:53AM
09:50AM
09:17AM
08:53AM
08:49AM
07:58AM
07:48AM
07:47AM
07:30AM
07:05AM
05:14AM
05:03AM
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dubovsky FilipPresident, R&DMay 14 '24Option Exercise6.9719,652136,97486,265May 15 09:15 PM
Dubovsky FilipPresident, R&DMay 14 '24Sale13.9047,312657,63738,953May 15 09:15 PM
O'Hara ElaineEVP, Chief Strategy OfficerMar 01 '24Option Exercise5.3919,600105,64419,600Mar 05 07:30 PM
Dubovsky FilipPresident, R&DDec 14 '23Option Exercise5.692,83316,12055,150Dec 18 05:00 PM
Dubovsky FilipPresident, R&DNov 05 '23Option Exercise7.061,4009,88452,994Nov 07 05:30 PM
Dubovsky FilipPresident, R&DSep 16 '23Option Exercise7.7112,64497,48557,702Sep 19 05:16 PM
Dubovsky FilipPresident, R&DJun 16 '23Option Exercise8.044,15533,40647,065Jun 21 04:40 PM